Pfizer fined for hiking drug price in UK
Pfizer | December 12, 2016
The latest setback for the global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines, came last week Wednesday in Britain. The anti-trust regulators imposed a record fine of US$107 million (£84.2 million) on Pfizer for overcharging the National Health Service (NHS) for an epilepsy treatment.